| Not Yet Recruiting | A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine ( Pertussis (Whooping Cough), Diphtheria, Tetanus | Phase 1 | 2026-04-20 |
| Enrolling By Invitation | A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Dip Rabies Prevention | Phase 3 | 2026-03-04 |
| Not Yet Recruiting | A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant) Influenza | Phase 1 | 2026-02-07 |
| Enrolling By Invitation | A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Sim Genital Herpes | Phase 1 | 2025-10-13 |
| Enrolling By Invitation | A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rab RabiesPrevention | Phase 1 | 2025-09-13 |
| Not Yet Recruiting | Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vacci Prevention of Influenza | Phase 3 | 2025-08-01 |
| Recruiting | Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Tria Prevent Whooping Cough, Prevent Diphtheria, Prevent Tetanus | Phase 3 | 2025-06-13 |
| Not Yet Recruiting | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogeni Prevention of Herpes Zoster | Phase 4 | 2025-05-01 |
| Not Yet Recruiting | Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Rabies Virus Infection | Phase 2 | 2024-07-31 |
| Not Yet Recruiting | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus T Clostridium Tetanus | EARLY_Phase 1 | 2024-04-10 |
| Unknown | Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine Influenza Prevention | Phase 4 | 2023-09-22 |
| Unknown | Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1 Rabies Virus Infection | EARLY_Phase 1 | 2023-04-30 |
| Unknown | The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine Influenza Prevention | Phase 2 | 2022-04-01 |
| Unknown | To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase Safety、Immunogenicity | Phase 1 / Phase 2 | 2021-12-10 |
| Unknown | The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine Influenza Prevention | Phase 1 | 2021-09-20 |
| Unknown | To Explore a Bridging Index for the Effectiveness of the Clinical Trial Randomized | N/A | 2021-04-16 |
| Completed | Study on Efficacy of Attenuated Zoster Vaccine, Live Herpes Zoster | Phase 3 | 2020-04-20 |
| Completed | A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV) Influenza | Phase 3 | 2016-11-01 |